Drug Patents owned by Athena
1. Drug name - FIBRICOR
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7569612 | ATHENA | Methods of use of fenofibric acid |
Aug, 2027
(4 years from now) | |
| US7741373 | ATHENA | Methods of use of fenofibric acid |
Aug, 2027
(4 years from now) | |
| US7915247 | ATHENA | Methods of use of fenofibric acid |
Aug, 2027
(4 years from now) | |
| US7741374 | ATHENA | Methods of use of fenofibric acid |
Aug, 2027
(4 years from now) | |
Drugs and Companies using FENOFIBRIC ACID ingredient
Treatment: Adjunctive therapy to diet in patients with hyperlipidemias; Adjunctive therapy to diet to patients with hypertriglyceridemia; Adjunctive therapy to diet in patients with hyperlipidemias; adjunctive therapy to diet in patients with mixed dyslipidemia; adjunctive therapy to diet to patients with hypertriglyceridemia; Adjunctive therapy to diet in patients with mixed dyslipidemia; adjunctive therapy to diet in patients with elevated cholesterol and/or lipid levels
Dosage: TABLET;ORAL
| Strength | Dosage | Availability |
|---|---|---|
| 35MG | TABLET;ORAL | Discontinued |
| 105MG | TABLET;ORAL | Prescription |
2. Drug name - NEXICLON XR
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8337890 | ATHENA | Modified release formulations containing drug-ion exchange resin complexes |
Apr, 2027
(4 years from now) | |
| US8623409 | ATHENA | Clonidine formulation |
Sep, 2031
(8 years from now) | |
| Strength | Dosage | Availability |
|---|---|---|
| EQ 0.17MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription |
| EQ 0.26MG BASE | TABLET, EXTENDED RELEASE;ORAL | Discontinued |
3. Drug name - QDOLO
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11103452 | ATHENA | Tramadol hydrochloride solution |
Sep, 2040
(17 years from now) | |
Drugs and Companies using TRAMADOL HYDROCHLORIDE ingredient
Treatment: Management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate
Dosage: SOLUTION;ORAL
| Strength | Dosage | Availability |
|---|---|---|
| 5MG/ML | SOLUTION;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.